Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

BUPIVACAINE HYDROCHLORIDE KIT

BUPIVACAINE HYDROCHLORIDE

Standard Dose
0.075%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview BUPIVACAINE HYDROCHLORIDE KIT is listed in Drugs@FDA under application 019978 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BUPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.075% Sponsor HOSPIRA Submission history Latest submission status date: 1999-01-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUPIVACAINE HYDROCHLORIDE KIT is listed in Drugs@FDA under application 019978 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BUPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.075% Sponsor HOSPIRA Submission history Latest submission status date: 1999-01-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.